November 10, 2015
BIOPHYTIS Invited to Attend the Jefferies 2015 Global Healthcare Conference. Read the press release
BIOPHYTIS Invited to Attend the Jefferies 2015 Global Healthcare Conference. Read the press release
BIOPHYTIS initiates the clinical batches production of BIO101, the first step in the ongoing phase 2b trial in the sarcopenic obesity. Click here to download the Press Release
BIOPHYTIS completes an international private placement of 6M€ to conduct its development strategy. Click here to download the Press Release
BIOPHYTIS strengthens its senior management team. Click here to download the Press Release
Interview of Stanislas Veillet, CEO of Biophytis on BFM Business (in French)
Major mobilisation at the SFO 2015 conference – the 121st Conference of the Société Française d’Ophtalmologie [French Society of Ophthalmology], from 9 to 12 May 2015, at the Palais des Congrès in Paris
Involvement in the 3ème Congrès francophone [3rd French-speaking conference] on assessing fragility in elderly subjects – “Prévention de la Dépendance – Rencontres Scientifiques sur la Sarcopénie” [The Prevention of Dependency – Scientific Fora on Sarcopenia] – Paris, 12 and 13 March 2015.